{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:45:56Z","timestamp":1791819956525,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijid.2026.108990","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:06:04Z","timestamp":1784304364000},"page":"108990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Seroprevalence and durability of West Nile virus (WNV) neutralizing antibody responses in asymptomatic adults"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-9751","authenticated-orcid":false,"given":"Gili","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Weiss-Ottolenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayan","family":"Gilboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Barda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Indnebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enosh","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-4607","authenticated-orcid":false,"given":"Gili","family":"Regev-Yochay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2026.108990_bib0001","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2437244","article-title":"West Nile virus in a changing climate: epidemiology, pathology, advances in diagnosis and treatment, vaccine designing and control strategies, emerging public health challenges\u2014a comprehensive review","volume":"14","author":"Singh","year":"2025","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10.1016\/j.ijid.2026.108990_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179774","article-title":"The seroprevalence of West Nile virus in Israel: a nationwide cross-sectional study","volume":"12","author":"Bassal","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108990_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/376230","article-title":"The global ecology and epidemiology of West Nile virus","volume":"2015","author":"Chancey","year":"2015","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.ijid.2026.108990_bib0004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/jama.2013.8042","article-title":"West Nile virus: review of literature","volume":"310","author":"Petersen","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ijid.2026.108990_bib0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jama.2025.8737","article-title":"West Nile virus: a review","volume":"334","author":"Gould","year":"2025","journal-title":"JAMA"},{"issue":"50","key":"10.1016\/j.ijid.2026.108990_bib0006","first-page":"1133","article-title":"Laboratory-acquired West Nile virus infections\u2014United States, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.ijid.2026.108990_bib0007","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijerph10083543","article-title":"Environmental drivers of West Nile fever epidemiology in Europe and Western Asia\u2014a review","volume":"10","author":"Paz","year":"2013","journal-title":"Int J Environ Res Public Health"},{"issue":"1665","key":"10.1016\/j.ijid.2026.108990_bib0008","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0561","article-title":"Climate change impacts on West Nile virus transmission in a global context","volume":"370","author":"Paz","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"21","key":"10.1016\/j.ijid.2026.108990_bib0009","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1111\/gcb.15842","article-title":"West Nile virus is predicted to be more geographically widespread in New York State and Connecticut under future climate change","volume":"27","author":"Keyel","year":"2021","journal-title":"Glob Chang Biol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108990_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012162","article-title":"The effect of temperature on the boundary conditions of West Nile virus circulation in Europe","volume":"18","author":"de Freitas Costa","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"48","key":"10.1016\/j.ijid.2026.108990_bib0011","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.48.2300258","article-title":"Ecological and clinical evidence of the establishment of West Nile virus in a large urban area in Europe, Berlin, Germany, 2021 to 2022","volume":"28","author":"Ruscher","year":"2023","journal-title":"Euro Surveill"},{"issue":"46","key":"10.1016\/j.ijid.2026.108990_bib0012","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.46.2001904","article-title":"First autochthonous human West Nile virus infections in the Netherlands, July to August 2020","volume":"25","author":"Vlaskamp","year":"2020","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.ijid.2026.108990_bib0013","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac125","article-title":"Rapid spread of a new West Nile virus lineage 1 associated with increased risk of neuroinvasive disease during a large outbreak in northern Italy, 2022: one health analysis","volume":"31","author":"Barzon","year":"2022","journal-title":"J Travel Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.108990_bib0014","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1017\/S0950268816000042","article-title":"Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic","volume":"145","author":"Williamson","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.ijid.2026.108990_bib0015","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40121-025-01140-3","article-title":"West Nile virus outbreak in Israel 2024 compared with previous seasons: a retrospective study","volume":"14","author":"Katzenellenbogen","year":"2025","journal-title":"Infect Dis Ther"},{"issue":"30","key":"10.1016\/j.ijid.2026.108990_bib0016","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.30.2400457","article-title":"Early rise of West Nile fever in Israel, June 2024","volume":"29","author":"Mor","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2026.108990_bib0017","series-title":"West Nile virus disease","year":"2024"},{"issue":"1","key":"10.1016\/j.ijid.2026.108990_bib0018","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.1.1800662","article-title":"Epidemiologic and phylogenetic analysis of the 2018 West Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I","volume":"24","author":"Lustig","year":"2019","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.ijid.2026.108990_bib0019","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.4269\/ajtmh.21-1234","article-title":"Duration of West Nile virus immunoglobulin M antibodies up to 81 months following West Nile Virus disease onset","volume":"106","author":"Staples","year":"2022","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.ijid.2026.108990_bib0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.4269\/ajtmh.13-0232","article-title":"Persistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus","volume":"89","author":"Murray","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"16","key":"10.1016\/j.ijid.2026.108990_bib0021","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ijid.2026.108990_bib0022","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108990_bib0023","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1038\/s41467-022-35480-2","article-title":"Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up","volume":"13","author":"Canetti","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijid.2026.108990_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2012.11.016","article-title":"Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses","volume":"437","author":"Obara","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2026.108990_bib0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10096-005-0061-3","article-title":"Post-epidemic serosurvey of West Nile fever in Israel","volume":"24","author":"Chowers","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2026.108990_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1743-422X-7-132","article-title":"First serological evidence of West Nile virus in human rural populations of Gabon","volume":"7","author":"Pourrut","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.ijid.2026.108990_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.968582","article-title":"Immune response to arbovirus infection in obesity","volume":"13","author":"Hameed","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2026.108990_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13216","article-title":"The impact of obesity on immune response to infection: plausible mechanisms and outcomes","volume":"22","author":"Muscogiuri","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/j.ijid.2026.108990_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739025","article-title":"Obesity enhances disease severity in female mice following West Nile virus infection","volume":"12","author":"Geerling","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.108990_bib0030","first-page":"1","article-title":"Estimated cumulative incidence of West Nile virus infection in us adults, 1999\u20132010","volume":"28","author":"Petersen","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2026.108990_bib0031","first-page":"34","article-title":"West Nile virus IgM and IgG antibodies three years post- infection","volume":"19","author":"Papa","year":"2015","journal-title":"Hippokratia"},{"issue":"9","key":"10.1016\/j.ijid.2026.108990_bib0032","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1128\/JCM.43.9.4316-4320.2005","article-title":"Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors","volume":"43","author":"Prince","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.ijid.2026.108990_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145516","article-title":"Durable SARS-CoV-2 B cell immunity after mild or severe disease","volume":"131","author":"Ogega","year":"2021","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ijid.2026.108990_bib0034","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152042","article-title":"SARS-CoV-2\u2013specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies","volume":"132","author":"Jeffery-Smith","year":"2022","journal-title":"J Clin Invest"},{"issue":"15","key":"10.1016\/j.ijid.2026.108990_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00760-22","article-title":"Persistent maintenance of intermediate memory B cells following SARS-CoV-2 infection and vaccination recall response","volume":"96","author":"Pu\u0161nik","year":"2022","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108990_bib0036","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.immuni.2020.09.001","article-title":"Affinity-restricted memory B cells dominate recall responses to heterologous flaviviruses","volume":"53","author":"Wong","year":"2020","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.ijid.2026.108990_bib0037","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/JVI.02155-10","article-title":"Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus","volume":"85","author":"Hofmeister","year":"2011","journal-title":"J Virol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:48:45Z","timestamp":1791816525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226006259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1201971226006259"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108990","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence and durability of West Nile virus (WNV) neutralizing antibody responses in asymptomatic adults","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108990"}}